Cargando…

Multivariate data analysis identifies natural clusters of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND)

BACKGROUND: Tuberous Sclerosis Complex (TSC), a multi-system genetic disorder, is associated with a wide range of TSC-Associated Neuropsychiatric Disorders (TAND). Individuals have apparently unique TAND profiles, challenging diagnosis, psycho-education, and intervention planning. We proposed that i...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Petrus J., Leclezio, Loren, Gardner-Lubbe, Sugnet, Krueger, Darcy, Sahin, Mustafa, Sparagana, Steven, De Waele, Liesbeth, Jansen, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543869/ https://www.ncbi.nlm.nih.gov/pubmed/34689816 http://dx.doi.org/10.1186/s13023-021-02076-w

Ejemplares similares

International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
por: de Vries, Petrus J., et al.
Publicado: (2023)

The research landscape of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND)—a comprehensive scoping review
por: Vanclooster, Stephanie, et al.
Publicado: (2022)

Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
por: Alperin, Samuel, et al.
Publicado: (2021)

Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project
por: de Vries, Petrus J., et al.
Publicado: (2020)

Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem)
por: Heunis, Tosca-Marie, et al.
Publicado: (2022)

New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND)
por: Gipson, Tanjala T., et al.
Publicado: (2017)

Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype
por: de Vries, Petrus J., et al.
Publicado: (2020)

Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders
por: Krueger, Darcy A., et al.
Publicado: (2017)

TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study
por: de Vries, Petrus J., et al.
Publicado: (2018)

Tuberous sclerosis complex-associated neuropsychiatric disorder (TAND) in a low-resource setting – From seizure to psychosis: A case report
por: Pokharel, Shashwat, et al.
Publicado: (2020)

Involvement of mental health professionals in the treatment of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey
por: Waltereit, Robert, et al.
Publicado: (2021)

De novo mutation of the TSC2 gene in patient with Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND) Phenotype: a case report
por: Triono, Agung, et al.
Publicado: (2023)

The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1
por: Cervi, Francesca, et al.
Publicado: (2020)

Tuberous Sclerosis Complex Patients’ Needs and Difficulties—Results of TAND Questionnaire Analysis in Polish Adult Population
por: Marcinkowska, Anna B., et al.
Publicado: (2022)

Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex
por: Sparagana, Steven, et al.
Publicado: (2017)

Deep learning in rare disease. Detection of tubers in tuberous sclerosis complex
por: Sánchez Fernández, Iván, et al.
Publicado: (2020)

Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
por: Krueger, Darcy A., et al.
Publicado: (2013)

Visualisation of quadratic discriminant analysis and its application in exploration of microbial interactions
por: Gardner-Lubbe, Sugnet, et al.
Publicado: (2015)

Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
por: Franz, David N., et al.
Publicado: (2016)

Cardiovascular Manifestations of Tuberous Sclerosis Complex and Summary of the Revised Diagnostic Criteria and Surveillance and Management Recommendations From the International Tuberous Sclerosis Consensus Group
por: Hinton, Robert B., et al.
Publicado: (2014)

Tuberous sclerosis: a review of the past, present, and future
por: UYSAL, Sanem Pınar, et al.
Publicado: (2020)

Self-injury and aggression in tuberous sclerosis complex: cross syndrome comparison and associated risk markers
por: Eden, Kate E, et al.
Publicado: (2014)

Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex
por: Ritter, David M., et al.
Publicado: (2022)

Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial
por: Thiele, Elizabeth A., et al.
Publicado: (2021)

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
por: Ellwanger, Kristina, et al.
Publicado: (2017)

The genomic landscape of tuberous sclerosis complex
por: Martin, Katie R., et al.
Publicado: (2017)

Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
por: Müller, Annelieke R., et al.
Publicado: (2023)

Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness
por: Kingswood, J Chris, et al.
Publicado: (2019)

EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors
por: Ellwanger, Kristina, et al.
Publicado: (2015)

Understanding biplots
por: Gower, John C, et al.
Publicado: (2010)

Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
por: Müller, Annelieke R., et al.
Publicado: (2023)

Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder
por: Prohl, Anna K., et al.
Publicado: (2019)

Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex
por: Afshar Saber, Wardiya, et al.
Publicado: (2020)

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
por: Fogarasi, Andras, et al.
Publicado: (2016)

The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma
por: Bissler, John J., et al.
Publicado: (2017)

Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)
por: Sauter, Matthias, et al.
Publicado: (2021)

Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis
por: Kong, Sek Won, et al.
Publicado: (2014)

Abnormal White Matter Microstructure in the Limbic System Is Associated With Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders
por: Sato, Akemi, et al.
Publicado: (2022)

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex
por: Kingswood, J. Chris, et al.
Publicado: (2021)

Auditory Processing of Speech and Tones in Children With Tuberous Sclerosis Complex
por: O’Brien, Amanda M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aqqaem5emarbgth9943uatd95e